Garmin Cloned WHOOP's Hardware and Deleted the Subscription
When the Product Is Interchangeable, the Fight Moves to the Model Around It
Parallels: what aesthetics can learn from industries that have nothing to do with it.
On July 24, 2026, Garmin launched the CIRQA, a screen-free band built to compete directly with WHOOP. It is worth looking closely at what Garmin chose to copy and what it chose to change. The CIRQA looks a great deal like the WHOOP 5.0, down to the fabric loop worn on the wrist or the upper arm. It runs a last-generation sensor rather than Garmin's newest. On the hardware, it is a deliberate me-too, at parity or a step behind. Then Garmin changed the one thing that was never a product feature at all. The CIRQA carries no subscription. You buy it once, for about two hundred dollars, and the full experience lives in the free Garmin app with no recurring fee. WHOOP works the opposite way. It has no free tier, and the device is inert without an active paid membership. Garmin did not try to win the sensor war. It attacked the business model instead, and that decision is the whole story.
Finish the essay. Join the MargaZine.
The MargaZine is free. One email unlocks the full library and brings every Monday drop to your inbox. No spam; unsubscribe anytime.
The product was never going to be the difference
Start with what Garmin conceded. The CIRQA does not out-feature the WHOOP 5.0, and Garmin did not pretend otherwise. It shipped a familiar design and an older sensor into a category where the bands have become largely interchangeable to the average buyer. This is the ordinary fate of a maturing hardware category. The core measurements converge, the differences shrink to the margins, and one more optical heart-rate band is not meaningfully better than the last. Garmin appears to have understood that a feature-by-feature fight against the category leader was expensive, hard to win, and mostly beside the point. When the product is a commodity, trying to make it slightly better spends your effort in the one place where advantage is hardest to hold. So Garmin looked elsewhere for the wedge.
It competed on the model around the molecule
The wedge Garmin found was the recurring fee. WHOOP does not sell a device. It sells a membership, with plans that run from roughly two hundred to three hundred and sixty dollars a year, and the hardware is bundled in. Cancel the membership and the band stops working. The history you accumulated becomes inaccessible until you pay again. There is no free tier and no way to own the device outright. That model built WHOOP. It also built a quiet resentment. That resentment surfaced this year, when the company began charging existing members an upgrade fee to move to new hardware. Many longtime members publicly called the move a slap in the face. Garmin walked straight into the opening. It priced the ongoing layer at zero. The app is free, the data is free, and the premium features are optional. For the large group of buyers who want the recovery-tracking experience and refuse to rent it forever, Garmin now offers the one thing WHOOP structurally cannot. It gives away the layer WHOOP charges rent on. The product is a near-copy. The economic relationship is the reverse, and that is where Garmin chose to fight.
The aesthetics parallel is the loyalty program
Aesthetics runs this exact play, and it runs it constantly, because its core products have the same problem the bands do. To a practice, the leading neurotoxins are close enough to interchangeable, and so are many of the fillers. The molecule is rarely the reason one brand gets chosen over another. So the manufacturers, like Garmin, compete on the model wrapped around the molecule rather than on the molecule itself. The wrapper is the loyalty program. The major players surround their commoditized products with consumer rewards, tiered rebates, bundles, and practice-level economics. All of it is designed to do one thing, which is to earn the right to be the default. A patient enrolled in a rewards program arrives with a reason to ask for that brand by name. A practice sitting inside a tiered rebate structure has a reason to reach for that vial rather than the equivalent one beside it. None of that value lives in the product. It lives in the program, at a different level of the value chain. It is deployed to win favor, to earn the recommendation, and ultimately to earn the injection. The company is buying the default position with economics, because it cannot buy it with the molecule.
The catch, and the version that lasts
Competing on the model is powerful, and it is also easy to get wrong. The first problem is that the move can be copied. Garmin is not the only subscription-free band, and a cheaper one from Fitbit already sits below it, so removing the fee is a wedge that others can remove too. Price is the least defensible ground there is. A loyalty program carries the same vulnerability. If the program is only a discount, it invites a discount war, and the manufacturers bid rebates against each other until the margin is gone and no one has gained a durable inch. The version that lasts stops being a discount and becomes a relationship. It accumulates something a competitor cannot instantly match. That is the patient's habit and history, the practice's integration and switching cost, and the data and trust that build up over years of use. That is the difference between a program that rents loyalty by the month and one that compounds it. Garmin has bought attention with price. Whether it keeps that attention depends on whether the ecosystem around the free app grows sticky enough to hold a customer who came in for the savings. The same test decides which aesthetic loyalty programs become a real moat and which are only a standing invitation to the next rebate. The molecule was always going to be interchangeable. The thing built around it does not have to be.
The migration of competition away from an interchangeable product and toward the economic model wrapped around it is one of the defining dynamics in aesthetics, and loyalty programs are its clearest expression. Helping manufacturers design programs that build a durable relationship rather than fund a rebate war, and that earn the right to be recommended and injected on something sturdier than price, is a meaningful part of what I do. If your product sits in a commoditizing category and your loyalty program is starting to look like a discount, that is a strategic problem worth solving before the margin goes, and it is a good place to begin a conversation.
Schedule a consultationA pharmacist turned commercial leader who has followed products across the entire value chain — from clinical development to launch, loyalty, and lifecycle — at three of the industry’s largest names.
Work with Marga →References & further reading
- On Garmin’s screen-free CIRQA band and its subscription-free positioning against WHOOP. Coverage — Garmin CIRQA.
- On WHOOP’s membership model and the 2026 hardware-upgrade fee backlash. Coverage — WHOOP upgrade fee.
The frameworks and commercial analysis here are Marga Partners’ own; the factual claims rest on the sources cited.